News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
235,136 Results
Type
Article (5117)
Company Profile (24)
Press Release (229995)
Multimedia
Podcasts (3)
Webinars (4)
Section
Business (82268)
Career Advice (463)
Deals (15057)
Drug Delivery (9)
Drug Development (19077)
Employer Resources (30)
FDA (3684)
Job Trends (3918)
News (120206)
Policy (7510)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (302)
Accelerated approval (10)
Adcomms (4)
Allergies (20)
Alliances (14815)
ALS (52)
Alzheimer's disease (326)
Antibody-drug conjugate (ADC) (71)
Approvals (3828)
Artificial intelligence (129)
Autoimmune disease (61)
Automation (10)
Bankruptcy (97)
Best Places to Work (2864)
Biosimilars (38)
Biotechnology (22)
Bladder cancer (43)
Brain cancer (15)
Breast cancer (125)
Cancer (1111)
Cardiovascular disease (80)
Career advice (396)
Career pathing (4)
CAR-T (75)
CDC (3)
Celiac Disease (1)
Cell therapy (194)
Cervical cancer (8)
Clinical research (17001)
Collaboration (456)
Compensation (448)
Complete response letters (12)
COVID-19 (315)
CRISPR (17)
C-suite (467)
Cystic fibrosis (28)
Data (1760)
Denatured (2)
Depression (26)
Dermatology (21)
Diabetes (100)
Diagnostics (2181)
Digital health (12)
Diversity (1)
Diversity, equity & inclusion (13)
Drug discovery (48)
Drug pricing (15)
Drug shortages (2)
Duchenne muscular dystrophy (50)
Earnings (43865)
Editorial (5)
Employer branding (6)
Employer resources (32)
Events (39742)
Executive appointments (476)
FDA (4545)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (7)
Frontotemporal dementia (14)
Funding (396)
Gene editing (30)
Generative AI (7)
Gene therapy (120)
GLP-1 (157)
Government (437)
Guidances (203)
Healthcare (5084)
HIV (13)
Huntington's disease (6)
IgA nephropathy (16)
Immunology and inflammation (46)
Immuno-oncology (13)
Indications (35)
Infectious disease (352)
Inflammatory bowel disease (38)
Inflation Reduction Act (3)
Influenza (10)
Intellectual property (36)
Interviews (53)
IPO (7888)
IRA (3)
Job creations (1123)
Job search strategy (361)
JPM (4)
Kidney cancer (13)
Labor market (13)
Layoffs (110)
Leadership (6)
Legal (2338)
Liver cancer (22)
Longevity (3)
Lung cancer (126)
Lymphoma (83)
Machine learning (8)
Management (10)
Manufacturing (196)
MASH (59)
Medical device (3945)
Medtech (3973)
Mergers & acquisitions (7632)
Metabolic disorders (274)
mRNA (12)
Multiple sclerosis (21)
NASH (6)
Neurodegenerative disease (74)
Neuropsychiatric disorders (13)
Neuroscience (636)
NextGen: Class of 2026 (1674)
Non-profit (736)
Now hiring (7)
Obesity (108)
Opinion (33)
Ovarian cancer (42)
Pain (31)
Pancreatic cancer (56)
Parkinson's disease (69)
Partnered (6)
Patents (59)
Patient recruitment (130)
Peanut (6)
People (25529)
Pharmaceutical (7)
Pharmacy benefit managers (2)
Phase 1 (5086)
Phase 2 (7393)
Phase 3 (5895)
Pipeline (3176)
Policy (24)
Postmarket research (625)
Preclinical (1970)
Press Release (66)
Prostate cancer (69)
Psychedelics (3)
Radiopharmaceuticals (125)
Rare diseases (226)
Real estate (1889)
Recruiting (8)
Regulatory (5711)
Reports (18)
Research institute (309)
Resumes & cover letters (69)
Rett syndrome (25)
RNA editing (2)
RSV (2)
Schizophrenia (58)
Series A (65)
Series B (66)
Sickle cell disease (15)
Special edition (1)
Spinal muscular atrophy (36)
Sponsored (5)
Startups (1018)
Stomach cancer (1)
Supply chain (17)
Tariffs (7)
The Weekly (1)
Vaccines (97)
Venture capital (13)
Weight loss (39)
Women's health (8)
Worklife (1)
Date
Today (9)
Last 7 days (167)
Last 30 days (1063)
Last 365 days (8843)
2026 (3916)
2025 (9035)
2024 (11027)
2023 (13190)
2022 (18658)
2021 (19677)
2020 (18238)
2019 (13205)
2018 (10203)
2017 (10000)
2016 (9155)
2015 (12118)
2014 (9588)
2013 (7709)
2012 (8336)
2011 (8797)
2010 (8634)
Location
Africa (186)
Alabama (19)
Alaska (2)
Arizona (83)
Arkansas (2)
Asia (11902)
Australia (1721)
California (4247)
Canada (1303)
China (212)
Colorado (170)
Connecticut (204)
Delaware (82)
Europe (25970)
Florida (655)
Georgia (89)
Idaho (24)
Illinois (196)
India (26)
Indiana (136)
Iowa (9)
Japan (212)
Kansas (40)
Kentucky (19)
Louisiana (11)
Maine (57)
Maryland (414)
Massachusetts (3423)
Michigan (107)
Minnesota (224)
Mississippi (1)
Missouri (40)
Montana (18)
Nebraska (12)
Nevada (53)
New Hampshire (16)
New Jersey (1213)
New Mexico (5)
New York (963)
North Carolina (569)
North Dakota (5)
Northern California (2261)
Ohio (138)
Oklahoma (5)
Oregon (7)
Pennsylvania (733)
Puerto Rico (3)
Rhode Island (20)
South America (279)
South Carolina (19)
Southern California (1604)
Tennessee (74)
Texas (611)
United States (14815)
Utah (138)
Virginia (102)
Washington D.C. (17)
Washington State (367)
West Virginia (2)
Wisconsin (69)
Wyoming (1)
235,136 Results for "nordson corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Atrion Corporation Enters Into Merger Agreement with Nordson Corporation
Atrion Corporation (NASDAQ: ATRI), a developer and manufacturer of products primarily for medical applications, today announced that it has entered into an agreement and plan of merger with Nordson Corporation pursuant to which Nordson will acquire Atrion for $460 per share in cash, representing a total equity value of approximately $815 million.
May 28, 2024
·
9 min read
Press Releases
Quasar Medical Strengthens Global CDMO Platform with Acquisition of Nordson Medical’s Galway and Tecate Facilities
September 3, 2025
·
3 min read
Press Releases
Quasar Medical to Acquire Nordson MEDICAL Design and Development Business in Galway, Ireland, and Tecate, Mexico
May 30, 2025
·
4 min read
Press Releases
Quasar Medical Will Acquire Nordson MEDICAL Design and Development Business in Galway, Ireland, and Tecate, Mexico
May 29, 2025
·
4 min read
Press Releases
Britannia Life Sciences Provides Corporate Update
Corporate Treasury Positioned with Cash and Liquid Equity Holdings to Seed, Incubate and Accelerate New and Existing Operations
May 21, 2026
·
4 min read
Business
Nordson Corporation Reports Second Quarter Fiscal 2023 Results and Updates Annual Guidance
Nordson Corporation reported results for the fiscal second quarter ended April 30, 2023. Sales were $650 million, a 2% increase compared to the prior year’s second quarter sales of $635 million.
May 22, 2023
·
7 min read
Business
Nordson Corporation Announces Earnings Release and Webcast for Third Quarter Fiscal Year 2022
Nordson Corporation announced it will release third quarter fiscal year 2022 earnings on August 22, 2022 after the close of the market.
August 2, 2022
·
1 min read
Press Releases
Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
May 14, 2026
·
14 min read
Press Releases
Alnylam Issues 2025 Corporate Responsibility Report
May 19, 2026
·
4 min read
Business
Nordson Corporation Announces Updates to Its Board of Directors
Nordson Corporation announced the recent appointments of Dr. John DeFord, executive vice president and chief technology officer of Becton, Dickinson and Company, and Ms. Jennifer Parmentier, vice president and president – Motion Systems Group for Parker Hannifin Corporation, to its board of directors.
November 30, 2020
·
4 min read
1 of 23,514
Next
